Zentalis Pharmaceuticals Inc (NAS:ZNTL)
$ 11.65 0 (0%) Market Cap: 827.30 Mil Enterprise Value: 380.94 Mil PE Ratio: 0 PB Ratio: 1.80 GF Score: 36/100

Zentalis Pharmaceuticals Inc To Host A Webcast Event With Key Opinion Leader Transcript

Apr 08, 2022 / 08:00PM GMT
Release Date Price: $33.97 (-30.02%)
Operator

Greetings. Welcome to Zentalis Data Review KOL Event. (Operator Instructions) Please note this conference is being recorded.

I will now turn the conference over to your host, CEO, Dr. Tony Sun. Tony, you may begin.

Anthony Y. Sun
Zentalis Pharmaceuticals, Inc. - President, CEO & Executive Chairman

Great. Thank you for the introduction, and welcome, everybody to the Zentalis AACR 2022 Investor Event. I'm joined here today with our special guest, Dr. Katie Moore.

And maybe, Katie, you can help us out by just giving a little bit of your introduction about yourself.

Kathleen Moore;Stephenson Cancer Center;Anthony Y. Sun
Zentalis

Great. Thank you so much, and good afternoon, everyone. I am Dr. Kathleen Moore. I'm a gynecologic-oncologist at the Stephenson Cancer Center in Oklahoma City, where I serve as the Associate Director of Clinical Research and Director of Phase I clinical trials for our cancer center. I'm very excited to be here today.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot